Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Johannesburg Stock Exchange  >  Dis-Chem Pharmacies Ltd    DCPJ   ZAE000227831

DIS-CHEM PHARMACIES LTD (DCPJ)
Mes dernières consult.
Most popular
  Report  
No quotes available
-- ZAR   --.--%
05/17DIS-CHEM PHARMA : Annual forecast results
CO
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Dis Chem Pharmacies : Workers threaten countrywide strike at Dis-Chem Pharmacies

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/13/2018 | 10:18am CEST

File picture: Henk Kruger

Johannesburg - The National Union of Public Service and Allied Workers (NUPSAW) said late Friday that it was currently preparing for a strike at Dis-Chem Pharmacies across the country over the recognition of its organisational rights.

NUPSAW, an affiliate of the South African Federation of Trade Unions (Saftu), said part of the action will take place at the Dis-Chem warehouse in Midrand, Johannesburg. The strike is expected to begin at 5am on Wednesday.

The union said that Dis-Chem refused to grant it organisational rights in terms of section 21 of the Labour Relations Act (LRA).

Section 21 of the LRA sets out considerations which the Commission for Conciliation, Mediation and Arbitration (CCMA) must take into account when it resolves a dispute about organisational rights -- whether or not a trade union is a representative trade union.

A dispute between NUPSAW and Dis-Chem was referred for conciliation to the CCMA in December 2017 but the matter remained unresolved. A certificate of non-resolution concerning organisational rights was then issued by the CCMA Commissioner.

"This gives our members the right to strike after giving seven days' notice in terms of section 21 of the Labour Relations Act," NUPSAW said in a statement.

"The employer's stubborn and extreme behaviour regarding the union's organisational rights has now set the stage for conflict and has left us with no other option but take this very unfortunate and painful decision, considering that it might also affect the sick and the frail who buy from Dis-Chem pharmacies."

NUPSAW said that Dis-Chem had also "inflicted excruciating pain" to employees who are its members on matters regarding their annual bonuses in December 2017.

"As NUPSAW our mission is to serve the best interest of our members, to fight discrimination on all levels and to ensure the distribution of economic resources in a just, equitable and humane manner."

African News Agency

(c) 2018 Cape Community 1999 - 2017 Independent Newspapers (Pty) Limited. All rights strictly reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DIS-CHEM PHARMACIES LTD
05/17DIS-CHEM PHARMACIES LTD : Annual forecast results
CO
05/07DIS CHEM PHARMACIES : Chem keeps on expanding with 21 new stores
AQ
05/04DIS CHEM PHARMACIES : Chem FY profits increase lead to store expansion
AQ
05/04DIS CHEM PHARMACIES : Chem FY profits increase lead to store expansion
AQ
01/25DIS CHEM PHARMACIES : Chem Pharamcies reaches agreement with union to end worker..
AQ
01/25DIS CHEM PHARMACIES : Chem Pharamcies reaches agreement with union to end worker..
AQ
01/16DIS CHEM PHARMACIES : SA Federation of Trade Unions backs workers strike at Dis-..
AQ
01/16DIS CHEM PHARMACIES : SA Federation of Trade Unions backs workers strike at Dis-..
AQ
01/16DIS CHEM PHARMACIES : Looming countrywide strike at Dis-Chem Pharmacies
AQ
01/13DIS CHEM PHARMACIES : Workers threaten countrywide strike at Dis-Chem Pharmacies
AQ
More news
Financials ( ZAR)
Sales 2019 22 436 M
EBIT 2019 1 389 M
Net income 2019 859 M
Debt 2019 855 M
Yield 2019 1,60%
P/E ratio 2019 25,82
P/E ratio 2020 19,65
EV / Sales 2019 1,03x
EV / Sales 2020 0,89x
Capitalization 22 276 M
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 34,4  ZAR
Spread / Average Target 30%
EPS Revisions
Managers
NameTitle
Ivan Leon Saltzman Chief Executive Officer & Director
Laurence Michael Nestadt Non-Executive Chairman
Rui Manuel Morais Chief Financial Officer & Executive Director
Lynette Frances Saltzman Executive Director & Managing Director
Mark John Bowman Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DIS-CHEM PHARMACIES LTD1 658
CVS HEALTH CORPORATION-2.39%73 382
WALGREENS BOOTS ALLIANCE-6.90%67 047
EXPRESS SCRIPTS HOLDING CO7.32%44 505
MCKESSON CORPORATION-4.53%30 040
AMERISOURCEBERGEN1.83%20 552